- An article from Ireland about the use of low-dose naltrexone for a wide variety of immune system disorders, including CFS. Unfortunately, there is a high-level UK health "expert" quoted here guessing that LDN is all about placebo effect, but hopefully the news coverage will help spread the word. Here's the latest update on my own use of low-dose naltrexone.
- A Los Angeles Times article about research into CFS in teens, following mononucleosis - mostly accurate, emphasizes that CFS causes debilitation in teens, plus an interesting statistic that 50% of teens who developed CFS after mono recovered within 2 years (hear that, Laura?)
- And a whole slew of news stories about a CFS-virus link in kids in the UK this week - about time, British friends, right? Here's one of the articles, from the BBC.
It's been a busy week here - we're all still trying to adjust to the early mornings and hectic evenings of the new school year. I'm doing OK, a bit better than last week. Looking forward to the weekend!